Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease ( CKD ) and Anemia at the 2024 American Society of Nephrology ( ASN ) Kidney Week

3 weeks ago

WATERTOWN, Mass., Oct. 25, 2024 ( GLOBE NEWSWIRE ) -- Disc Medicine, Inc. ( NASDAQ:IRON ) , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today presented ...

Ticker	Sentiment	Impact
IRON	Neutral	9 %